Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × Magnetic Resonance Imaging × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 6 Neoplasms 6 Breast Neoplasms 6 Pancreatic Neoplasms 5 Brain Neoplasms 5 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Uterine Cervical Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lung Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Liver Neoplasms 2 Leukemia 2 Hodgkin Disease 2 Glioma 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Neuroendocrine 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Thoracic Neoplasms 1 Thoracic Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Diseases 1 Spinal Cord Neoplasms 1 Rectal Neoplasms 1

Interventions

Rituximab 47 Cyclophosphamide 38 ibrutinib 22 fludarabine 22 acalabrutinib 20 venetoclax 18 Bendamustine Hydrochloride 18 zanubrutinib 15 Lenalidomide 15 CT-P10 13 fludarabine phosphate 12 Cytarabine 12 pirtobrutinib 11 obinutuzumab 11 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Etoposide 9 Vincristine 8 Doxorubicin 8 Biopsy 8 glofitamab 7 Whole-Body Irradiation 7 Mycophenolic Acid 6 Methotrexate 6 Melphalan 6 Peripheral Blood Stem Cell Transplantation 5 Immunotherapy, Adoptive 5 Cyclosporine 5 orelabrutinib 4 brexucabtagene autoleucel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡